Chobei Takeda & Co., Ltd. (1925–1943) Takeda Pharmaceutical Industries, Ltd. (English name only 1943–1961) Takeda Chemical Industries, Ltd. (English name only 1961–2004)[2]
Company type
Public KK
Traded as
TYO: 4502
NAG: 4502
FSE: 4502
NYSE: TAK
Nikkei 225 component (TYO)
TOPIX Core30 component (TYO)
Industry
Pharmaceuticals
Founded
Doshomachi, Osaka, Japan (12 June 1781; 243 years ago (1781-06-12))
Founder
Chobei Takeda I
Headquarters
Nihonbashi, Chuo, Tokyo
,
Japan
Key people
Yasuchika Hasegawa (Chairman of the Board) Christophe Weber[3] (President & CEO)
Revenue
¥4.03 trillion (FY 2022)[* 1]
Operating income
¥490.51 billion (FY 2022)[* 1]
Net income
¥317.02 billion (FY 2022)[* 1]
Total assets
¥13.96 trillion (FY 2022)[* 1]
Total equity
¥6.35 trillion (FY 2022)[* 1]
Owners
Nippon Life (2.24%)[4]
BNY Mellon (5.39%)[4]
JPMorgan Chase (3.50%)[4]
State Street Corporation (1.50%)
Number of employees
49,578 (2019)
18,378 in United States [5]
5,350 in Japan[6]
Website
www.takeda.com
Footnotes / references
^ abcde"Financial Results for Fiscal 2023" (PDF). Takeda Pharmaceutical Company Limited. May 11, 2023. Retrieved December 27, 2023.
The Takeda Pharmaceutical Company Limited[1] (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha)[takeꜜdajakɯçiŋkoꜜːɡʲoː] is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following its merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year.[7] The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo.[8][9] In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.[10] As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.[11]
^ ab"Company Facts | Takeda". www.takeda.com.
^"The History of Takeda – 1781 to 1944 | Takeda".
^Chris Gallagher (2015-03-15). Muralikumar Anantharaman (ed.). "Japan drugmaker Takeda says Christophe Weber to become CEO April 1". Reuters. Retrieved 2015-04-20.
^ abc"Share Data | Takeda".
^"Working at Takeda Pharmaceuticals NA".
^"Takeda offers early retirement to workers as young as 30". Nikkei Asia.
^"Financial Results for Fiscal 2012" (PDF). Takeda Pharmaceutical Company Limited. 2013-05-09. Retrieved 2013-06-13.
^"FAQ." Takeda Pharmaceutical Company. Retrieved on 2011-02-02. "Q : Where is Takeda located? A : The Head Office is located in Osaka, Japan, and the Tokyo Head Office is located in Tokyo, Japan."
^"Overview." Takeda Pharmaceutical Company. Retrieved on 2011-02-02. "Headquarters Head Office 1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645" and "Tokyo Head Office 12-10, Nihonbashi 2-chome, Chuo-ku, Tokyo 103-8668"
^"100 Best Companies to Work For 2012". Fortune. 2012-02-06. Retrieved 2018-03-29.[dead link]
^"Christophe Weber". Takeda. Archived from the original on 2024-04-15. Retrieved 2024-04-15.
and 25 Related for: Takeda Pharmaceutical Company information
The TakedaPharmaceuticalCompany Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical...
Takeda Oncology (originally Millennium Pharmaceuticals) is a biopharmaceutical company based in Cambridge, Massachusetts. It is a fully owned subsidiary...
The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated...
ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered...
after industry leader TakedaPharmaceuticalCompany. The IPO debuted at $2.4 billion, making it the largest for a pharmaceuticalcompany up to that time. In...
vaccine and had started phase 1 trials. The company has since been taken over by TakedaPharmaceuticalCompany. As of 2019[update], a bivalent (NoV GI.1/GII...
December 2013[update], ten different companies produced generic Adderall IR, while Teva Pharmaceutical Industries, Actavis, and Barr Pharmaceuticals manufactured generic...
biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of TakedaPharmaceuticalCompany. Baxalta inherited...
Takeda also competed at the 2010 Asian Games in Guangzhou, China. Reiko Takeda is the daughter of Kunio Takeda, chairman of Takedapharmaceutical company...
Note: TAP Pharmaceuticals was a joint venture between Abbott Laboratories and Takeda that was dissolved in 2008 per this press release: "Takeda, Abbott...
Canadian pharmacies as of March 2018. Shire was acquired by TakedaPharmaceuticalCompany in late 2018. In May 2019 Novartis reached an agreement to purchase...
Pharmaceuticals was formed in 1977 as a joint venture between the two global pharmaceuticalcompanies, Abbott Laboratories and TakedaPharmaceutical Co...
heart failure. It was developed by Syrrx, a company which was acquired by TakedaPharmaceuticalCompany in 2005. In 2020, it was the 295th most commonly...
Release. TakedaPharmaceuticalCompany Limited. 8 March 2013. "Takeda Submits Vedolizumab BLA". Drug Discovery and Development. 21 June 2013. "Takeda's New...
Nycomed is a Swiss pharmaceuticalcompany. Nycomed was acquired by TakedaPharmaceuticals in September 2011. Production was located in Norway, Denmark...
Delinquent Academy Ijuro Takeda, a modern Samurai descendant in the movie The Hunted Takeda (video game) TakedaPharmaceuticalCompany (Takeda; 武田薬品) 1990 Census...
suppression). Lansoprazole was originally synthesized at Takeda and was given the development name AG 1749. Takeda patented it in 1984 and the drug launched in 1991...
from the ADOPT trial. Following release of this statement, TakedaPharmaceuticalCompany, the developer of pioglitazone (sold as Actos in many markets)...
acquired by Takeda in 2011 and Wyeth was acquired by Pfizer in 2009. The patent protecting the drug was set to expire in 2010, but Teva Pharmaceuticals filed...
mixture of its (R)-(+) and (S)-(−)-enantiomers. The Takeda drug has a dual release pharmaceutical formulation, with two types of granules of dexlansoprazole...
mellitus. Voglibose is a research product of TakedaPharmaceuticalCompany, Japan's largest pharmaceuticalcompany. Vogilbose was discovered in 1981, and was...
The prodrug candesartan cilexetil is marketed by AstraZeneca and TakedaPharmaceuticals, commonly under the trade names Blopress, Atacand, Amias, and Ratacand...
first described in a 2019 patent filed by TakedaPharmaceuticalCompany. Firazorexton was studied by Takeda for the treatment of narcolepsy. It is a small-molecule...
Global Information
¥4.03 trillion (FY 2022)[* 1]